169 related articles for article (PubMed ID: 7535572)
1. Chronic nitric oxide synthase inhibition aggravates glomerular injury in rats with subtotal nephrectomy.
Fujihara CK; De Nucci G; Zatz R
J Am Soc Nephrol; 1995 Jan; 5(7):1498-507. PubMed ID: 7535572
[TBL] [Abstract][Full Text] [Related]
2. Sodium excess aggravates hypertension and renal parenchymal injury in rats with chronic NO inhibition.
Fujihara CK; Michellazzo SM; de Nucci G; Zatz R
Am J Physiol; 1994 May; 266(5 Pt 2):F697-705. PubMed ID: 8203552
[TBL] [Abstract][Full Text] [Related]
3. Chronic inhibition of nitric oxide synthesis. A new model of arterial hypertension.
Ribeiro MO; Antunes E; de Nucci G; Lovisolo SM; Zatz R
Hypertension; 1992 Sep; 20(3):298-303. PubMed ID: 1516948
[TBL] [Abstract][Full Text] [Related]
4. Angiotensin II subtype AT1 receptor blockade prevents hypertension and renal insufficiency induced by chronic NO-synthase inhibition in rats.
Hropot M; Langer KH; Wiemer G; Grötsch H; Linz W
Naunyn Schmiedebergs Arch Pharmacol; 2003 Mar; 367(3):312-7. PubMed ID: 12644905
[TBL] [Abstract][Full Text] [Related]
5. Losartan-hydrochlorothiazide association promotes lasting blood pressure normalization and completely arrests long-term renal injury in the 5/6 ablation model.
Fujihara CK; Malheiros DM; Zatz R
Am J Physiol Renal Physiol; 2007 Jun; 292(6):F1810-8. PubMed ID: 17344184
[TBL] [Abstract][Full Text] [Related]
6. Effects of chronic NO synthase inhibition in rats on renin-angiotensin system and sympathetic nervous system.
Zanchi A; Schaad NC; Osterheld MC; Grouzmann E; Nussberger J; Brunner HR; Waeber B
Am J Physiol; 1995 Jun; 268(6 Pt 2):H2267-73. PubMed ID: 7541960
[TBL] [Abstract][Full Text] [Related]
7. Combined mycophenolate mofetil and losartan therapy arrests established injury in the remnant kidney.
Fujihara CK; DE Lourdes Noronha I; Malheiros DMAC; Antunes GR; DE Oliveira IB; Zatz R
J Am Soc Nephrol; 2000 Feb; 11(2):283-290. PubMed ID: 10665935
[TBL] [Abstract][Full Text] [Related]
8. Glomerulosclerosis in the diet-induced obesity model correlates with sensitivity to nitric oxide inhibition but not glomerular hyperfiltration or hypertrophy.
Polichnowski AJ; Licea-Vargas H; Picken M; Long J; Bisla R; Williamson GA; Bidani AK; Griffin KA
Am J Physiol Renal Physiol; 2015 Nov; 309(9):F791-9. PubMed ID: 26109088
[TBL] [Abstract][Full Text] [Related]
9. Effect of salt intake and inhibitor dose on arterial hypertension and renal injury induced by chronic nitric oxide blockade.
Yamada SS; Sassaki AL; Fujihara CK; Malheiros DM; De Nucci G; Zatz R
Hypertension; 1996 May; 27(5):1165-72. PubMed ID: 8621212
[TBL] [Abstract][Full Text] [Related]
10. Angiotensin II and alpha 1-adrenergic tone in chronic nitric oxide blockade-induced hypertension.
Qiu C; Engels K; Baylis C
Am J Physiol; 1994 May; 266(5 Pt 2):R1470-6. PubMed ID: 8203622
[TBL] [Abstract][Full Text] [Related]
11. Modulation of glomerular hypertension defines susceptibility to progressive glomerular injury.
Simons JL; Provoost AP; Anderson S; Rennke HG; Troy JL; Brenner BM
Kidney Int; 1994 Aug; 46(2):396-404. PubMed ID: 7967351
[TBL] [Abstract][Full Text] [Related]
12. Large BP-dependent and -independent differences in susceptibility to nephropathy after nitric oxide inhibition in Sprague-Dawley rats from two major suppliers.
Griffin K; Polichnowski A; Licea-Vargas H; Picken M; Long J; Williamson G; Bidani A
Am J Physiol Renal Physiol; 2012 Jan; 302(1):F173-82. PubMed ID: 21937607
[TBL] [Abstract][Full Text] [Related]
13. Angiotensin blockade reverses hypertension during long-term nitric oxide synthase inhibition.
Pollock DM; Polakowski JS; Divish BJ; Opgenorth TJ
Hypertension; 1993 May; 21(5):660-6. PubMed ID: 7684026
[TBL] [Abstract][Full Text] [Related]
14. A nitric oxide-generating beta-blocking agent prevents renal injury in the rat remnant kidney model. Comparative study of two beta-blocking drugs, nipradilol and propranolol.
Takamitsu Y; Nakanishi T; Nishihara F; Hasuike Y; Izumi M; Inoue T; Hiraoka K; Itahana R; Miyagawa K
Nephron Physiol; 2003; 93(2):p42-50. PubMed ID: 12629270
[TBL] [Abstract][Full Text] [Related]
15. Relative roles of nitric oxide, prostanoids and angiotensin II in the regulation of canine glomerular hemodynamics. A micropuncture study.
Kramer HJ; Horacek V; Bäcker A; Vaneckova I; Heller J
Kidney Blood Press Res; 2004; 27(1):10-7. PubMed ID: 14583658
[TBL] [Abstract][Full Text] [Related]
16. Nitric oxide synthase inhibition in spontaneously hypertensive rats. Systemic, renal, and glomerular hemodynamics.
Ono H; Ono Y; Frohlich ED
Hypertension; 1995 Aug; 26(2):249-55. PubMed ID: 7543452
[TBL] [Abstract][Full Text] [Related]
17. Do ETA receptors participate in the hemodynamic and renal effects of chronic nitric oxide blockade?
Fujihara CK; De Nucci G; Zatz R
J Cardiovasc Pharmacol; 1995; 26 Suppl 3():S462-5. PubMed ID: 8587446
[TBL] [Abstract][Full Text] [Related]
18. Renal denervation prevents intraglomerular platelet aggregation and glomerular injury induced by chronic inhibition of nitric oxide synthesis.
Nakashima A; Matsuoka H; Yasukawa H; Kohno K; Nishida H; Nomura G; Imaizumi T; Morimatsu M
Nephron; 1996; 73(1):34-40. PubMed ID: 8742954
[TBL] [Abstract][Full Text] [Related]
19. Angiotensin II-induced renal responses in anesthetized rabbits: effects of N omega-nitro-L-arginine methyl ester and losartan.
Adachi Y; Hashimoto K; Hisa H; Yoshida M; Suzuki-Kusaba M; Satoh S
Eur J Pharmacol; 1996 Jul; 308(2):165-71. PubMed ID: 8840128
[TBL] [Abstract][Full Text] [Related]
20. Angiotensin-(1-7) and nitric oxide interaction in renovascular hypertension.
Nakamoto H; Ferrario CM; Fuller SB; Robaczewski DL; Winicov E; Dean RH
Hypertension; 1995 Apr; 25(4 Pt 2):796-802. PubMed ID: 7536715
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
